143 related articles for article (PubMed ID: 7690450)
1. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
Ellis J; Seidenberg M; Brann MR
Mol Pharmacol; 1993 Sep; 44(3):583-8. PubMed ID: 7690450
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
Tränkle C; Kostenis E; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
[TBL] [Abstract][Full Text] [Related]
3. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
Ellis J; Huyler J; Brann MR
Biochem Pharmacol; 1991 Oct; 42(10):1927-32. PubMed ID: 1741770
[TBL] [Abstract][Full Text] [Related]
4. Gallamine exerts biphasic allosteric effects at muscarinic receptors.
Ellis J; Seidenberg M
Mol Pharmacol; 1989 Feb; 35(2):173-6. PubMed ID: 2918854
[TBL] [Abstract][Full Text] [Related]
5. On the interaction of gallamine with muscarinic receptor subtypes.
Michel AD; Delmendo RE; Lopez M; Whiting RL
Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
[TBL] [Abstract][Full Text] [Related]
6. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991
[TBL] [Abstract][Full Text] [Related]
7. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
[TBL] [Abstract][Full Text] [Related]
8. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
9. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
Leppik RA; Miller RC; Eck M; Paquet JL
Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
Gillard M; Waelbroeck M; Christophe J
J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
[TBL] [Abstract][Full Text] [Related]
11. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
[TBL] [Abstract][Full Text] [Related]
12. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
Waelbroeck M; Robberecht P; De Neef P; Christophe J
J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
[TBL] [Abstract][Full Text] [Related]
13. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
14. Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.
Narayanan TK; Aronstam RS
Neurochem Res; 1986 Oct; 11(10):1397-406. PubMed ID: 3785535
[TBL] [Abstract][Full Text] [Related]
15. Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors.
Gnagey A; Ellis J
Biochem Pharmacol; 1996 Dec; 52(11):1767-75. PubMed ID: 8986140
[TBL] [Abstract][Full Text] [Related]
16. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
Ellis J; Lenox RH
Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
[TBL] [Abstract][Full Text] [Related]
17. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
[TBL] [Abstract][Full Text] [Related]
18. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
19. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.
Surichamorn W; Kim ON; Lee NH; Lai WS; el-Fakahany EE
Neurochem Res; 1988 Dec; 13(12):1183-91. PubMed ID: 3237310
[TBL] [Abstract][Full Text] [Related]
20. Competition between positive and negative allosteric effectors on muscarinic receptors.
Proska J; Tucek S
Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
